Literature DB >> 25016609

Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury.

Guillaume Canaud1, Joseph V Bonventre2.   

Abstract

For several decades, acute kidney injury (AKI) was generally considered a reversible process leading to complete kidney recovery if the individual survived the acute illness. Recent evidence from epidemiologic studies and animal models, however, have highlighted that AKI can lead to the development of fibrosis and facilitate the progression of chronic renal failure. When kidney injury is mild and baseline function is normal, the repair process can be adaptive with few long-term consequences. When the injury is more severe, repeated, or to a kidney with underlying disease, the repair can be maladaptive and epithelial cell cycle arrest may play an important role in the development of fibrosis. Indeed, during the maladaptive repair after a renal insult, many tubular cells that are undergoing cell division spend a prolonged period in the G2/M phase of the cell cycle. These tubular cells recruit intracellular pathways leading to the synthesis and the secretion of profibrotic factors, which then act in a paracrine fashion on interstitial pericytes/fibroblasts to accelerate proliferation of these cells and production of interstitial matrix. Thus, the tubule cells assume a senescent secretory phenotype. Characteristic features of these cells may represent new biomarkers of fibrosis progression and the G2/M-arrested cells may represent a new therapeutic target to prevent, delay or arrest progression of chronic kidney disease. Here, we summarize recent advances in our understanding of the biology of the cell cycle and how cell cycle arrest links AKI to chronic kidney disease.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25016609      PMCID: PMC4370290          DOI: 10.1093/ndt/gfu230

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  68 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Activation and involvement of p53 in cisplatin-induced nephrotoxicity.

Authors:  Qingqing Wei; Guie Dong; Tianxin Yang; Judit Megyesi; Peter M Price; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-01

3.  Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney.

Authors:  Fangming Lin; Ashley Moran; Peter Igarashi
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

4.  Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.

Authors:  Ching-Fang Wu; Wen-Chih Chiang; Chun-Fu Lai; Fan-Chi Chang; Yi-Ting Chen; Yu-Hsiang Chou; Ting-Hui Wu; Geoffrey R Linn; Hong Ling; Kwan-Dun Wu; Tun-Jun Tsai; Yung-Ming Chen; Jeremy S Duffield; Shuei-Liong Lin
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

5.  Histone deacetylase inhibitor enhances recovery after AKI.

Authors:  Chiara Cianciolo Cosentino; Nataliya I Skrypnyk; Lauren L Brilli; Takuto Chiba; Tatiana Novitskaya; Clara Woods; James West; Vasiliy N Korotchenko; Lee McDermott; Billy W Day; Alan J Davidson; Raymond C Harris; Mark P de Caestecker; Neil A Hukriede
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

Review 6.  Acute kidney injury and chronic kidney disease: an integrated clinical syndrome.

Authors:  Lakhmir S Chawla; Paul L Kimmel
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

Review 7.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

8.  Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey.

Authors:  Orfeas Liangos; Ron Wald; John W O'Bell; Lorilyn Price; Brian J Pereira; Bertrand L Jaber
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 8.237

Review 9.  Renal epithelial injury and fibrosis.

Authors:  Brigitte Kaissling; Michel Lehir; Wilhelm Kriz
Journal:  Biochim Biophys Acta       Date:  2013-03-01

10.  Protective effects and mechanisms of curcumin on podophyllotoxin toxicity in vitro and in vivo.

Authors:  Juan Li; Cai-Xia Dai; Hua Sun; Lu Jin; Chong-Yi Guo; Wei Cao; Jie Wu; Hai-Yan Tian; Cheng Luo; Wen-Cai Ye; Ren-Wang Jiang
Journal:  Toxicol Appl Pharmacol       Date:  2012-10-23       Impact factor: 4.219

View more
  60 in total

1.  Exosomes to the Rescue.

Authors:  Jessica Rossol-Allison; Christopher J Ward
Journal:  J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 10.121

Review 2.  Cellular senescence in renal ageing and disease.

Authors:  Ines Sturmlechner; Matej Durik; Cynthia J Sieben; Darren J Baker; Jan M van Deursen
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

3.  Renal replacement in 2050: from renal support to renal replacement?

Authors:  Lui G Forni; Michael Darmon; Miet Schetz
Journal:  Intensive Care Med       Date:  2017-02-04       Impact factor: 17.440

4.  Cyclin G1 and TASCC regulate kidney epithelial cell G2-M arrest and fibrotic maladaptive repair.

Authors:  Guillaume Canaud; Craig R Brooks; Seiji Kishi; Kensei Taguchi; Kenji Nishimura; Sato Magassa; Adam Scott; Li-Li Hsiao; Takaharu Ichimura; Fabiola Terzi; Li Yang; Joseph V Bonventre
Journal:  Sci Transl Med       Date:  2019-01-23       Impact factor: 17.956

5.  CRYAB protects cardiomyocytes against heat stress by preventing caspase-mediated apoptosis and reducing F-actin aggregation.

Authors:  Bin Yin; Shu Tang; Jiao Xu; Jiarui Sun; Xiaohui Zhang; Yubao Li; Endong Bao
Journal:  Cell Stress Chaperones       Date:  2018-09-24       Impact factor: 3.667

6.  Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.

Authors:  Sonja Djudjaj; Ina V Martin; Eva M Buhl; Nina J Nothofer; Lin Leng; Marta Piecychna; Jürgen Floege; Jürgen Bernhagen; Richard Bucala; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2017-08-11       Impact factor: 10.121

Review 7.  The regulatory role of HIF-1 in tubular epithelial cells in response to kidney injury.

Authors:  Yumei Qiu; Xiaowen Huang; Weichun He
Journal:  Histol Histopathol       Date:  2019-11-06       Impact factor: 2.303

8.  Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy.

Authors:  Hee-Seong Jang; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-15

9.  Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Authors:  Min Tao; Yingfeng Shi; Lunxian Tang; Yi Wang; Lu Fang; Wei Jiang; Tao Lin; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

10.  Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.

Authors:  Yunhe Zhang; Jianan Zou; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2020-04-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.